| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,794 |
11,221 |
$602K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,019 |
986 |
$78K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,125 |
3,077 |
$73K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,182 |
1,144 |
$60K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,173 |
1,159 |
$45K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,724 |
3,672 |
$43K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
995 |
986 |
$41K |
| 92587 |
|
1,866 |
1,863 |
$41K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,529 |
1,496 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
699 |
671 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
444 |
440 |
$18K |
| 92558 |
|
2,609 |
2,538 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
274 |
265 |
$11K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
509 |
498 |
$10K |
| 90686 |
|
2,111 |
2,048 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
217 |
211 |
$9K |
| 99177 |
|
2,106 |
2,082 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
397 |
196 |
$6K |
| 90461 |
|
307 |
303 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
236 |
231 |
$4K |
| 90619 |
|
26 |
26 |
$3K |
| 96127 |
|
785 |
757 |
$3K |
| 96160 |
|
742 |
730 |
$2K |
| 90670 |
|
164 |
161 |
$891.15 |
| 99051 |
|
608 |
600 |
$528.04 |
| 90651 |
|
41 |
41 |
$522.37 |
| 90716 |
|
58 |
55 |
$461.95 |
| 87081 |
|
69 |
68 |
$378.93 |
| 3008F |
|
37 |
37 |
$370.00 |
| 90707 |
|
54 |
53 |
$174.62 |
| 90633 |
|
77 |
75 |
$145.06 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
274 |
263 |
$140.76 |
| 90473 |
|
12 |
12 |
$138.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$84.30 |
| 90700 |
|
44 |
44 |
$34.15 |
| 94760 |
|
2,403 |
2,279 |
$31.07 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
5,562 |
5,480 |
$20.00 |
| 99072 |
|
895 |
872 |
$0.00 |
| 90680 |
|
26 |
26 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
277 |
275 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
2,799 |
2,781 |
$0.00 |
| 90698 |
|
43 |
43 |
$0.00 |
| 90744 |
|
27 |
27 |
$0.00 |
| 91307 |
|
14 |
12 |
$0.00 |